A detailed history of Cutler Group LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 600 shares of AKRO stock, worth $17,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 300 100.0%
Holding current value
$17,826
Previous $7,000 114.29%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$17.76 - $31.18 $5,328 - $9,354
300 Added 100.0%
600 $15,000
Q4 2023

Jan 18, 2024

BUY
$11.38 - $50.33 $3,414 - $15,099
300 New
300 $7,000
Q3 2022

Oct 25, 2022

BUY
$10.15 - $34.05 $1,015 - $3,404
100 New
100 $3,000
Q2 2021

Jul 19, 2021

SELL
$24.81 - $32.35 $19,848 - $25,880
-800 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$24.04 - $34.19 $19,232 - $27,352
800 New
800 $23,000
Q4 2020

Jan 21, 2021

SELL
$25.12 - $29.89 $12,560 - $14,945
-500 Closed
0 $0
Q3 2020

Oct 27, 2020

SELL
$30.79 - $39.92 $12,316 - $15,968
-400 Reduced 44.44%
500 $15,000
Q2 2020

Jul 22, 2020

BUY
$19.25 - $26.76 $11,550 - $16,056
600 Added 200.0%
900 $22,000
Q1 2020

May 07, 2020

BUY
$12.8 - $27.05 $3,840 - $8,115
300 New
300 $6,000

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.38B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.